SCHEMBL24567289

SCHEMBL24567289

c1ccc(COc2cnn3ccc(N4CCOCC4)cc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.48
LRRK2 Q5S007 1/20 0.48
SLCO1B1 Q9Y6L6 1/20 0.48
EPHB3 P54753 1/20 0.47
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
CYP11B2 P19099 1/20 0.46
ALDH1A1 P00352 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PRKDC P78527 2/20 0.43
ATM Q13315 1/20 0.43
AGXT P21549 1/20 0.43
PIK3CG P48736 1/20 0.43
ALKBH1 Q13686 1/20 0.43
ATR Q13535 1/20 0.42
ATRIP Q8WXE1 1/20 0.42
P2RY12 Q9H244 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19381144 0.74 CCR5 (0.62) CYP3A4LRRK2SLCO1B1CNR1CNR2
SCHEMBL14259466 0.73 AGXT (0.52) CYP3A4LRRK2SLCO1B1CNR1CNR2
SCHEMBL3320288 0.73 ATM (0.52) CYP3A4LRRK2SLCO1B1CNR1CNR2
SCHEMBL4295800 0.72 MAPT (0.61) CYP3A4LRRK2SLCO1B1ALDH1A1MAPK1
SCHEMBL1735538 0.72 ALDH1A1 (0.56) CYP3A4LRRK2SLCO1B1CNR1CNR2
SCHEMBL1263059 0.72 AGXT (0.61) ALDH1A1ALOX15TSHRMAPK1HSD17B10
SCHEMBL24567287 0.72 EPHB3 (0.53) EPHB3ALDH1A1PRKDCPIK3CGMEN1
SCHEMBL24567286 0.72 EPHB3 (0.53) EPHB3ALDH1A1ALOX15TSHRPRKDC
SCHEMBL33913 0.72 SMPD3 (0.55) EPHB3ALDH1A1ALOX15TSHRPRKDC
SCHEMBL24567313 0.72 EPHB3 (0.50) EPHB3ALDH1A1ALOX15TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140527-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed